Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. En savoir plus sur Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. En savoir plus sur Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis? En savoir plus sur Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?
Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. En savoir plus sur Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population.
[Utilization of alfacalcidol and active vitamin D analogs in chronic kidney disease]. En savoir plus sur [Utilization of alfacalcidol and active vitamin D analogs in chronic kidney disease].
Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations. En savoir plus sur Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations.
Bone, inflammation and the bone marrow niche in chronic kidney disease: what do we know? En savoir plus sur Bone, inflammation and the bone marrow niche in chronic kidney disease: what do we know?
Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet). En savoir plus sur Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet).
Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis. En savoir plus sur Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis.
Hemodiafiltration Versus Hemodialysis and Survival in Patients With ESRD: The French Renal Epidemiology and Information Network (REIN) Registry. En savoir plus sur Hemodiafiltration Versus Hemodialysis and Survival in Patients With ESRD: The French Renal Epidemiology and Information Network (REIN) Registry.